The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. 2011

Tomas Ganz, and Elizabeta Nemeth
Department of Pulmonary & Critical Care Medicine, University of California-Los Angeles, Los Angeles, CA, USA. tganz@mednet.ucla.edu

The review summarizes the current understanding of the role of hepcidin and ferroportin in normal iron homeostasis and its disorders. The various approaches to therapeutic targeting of hepcidin and ferroportin in iron-overload disorders (mainly hereditary hemochromatosis and β-thalassemia) and iron-restrictive anemias (anemias associated with infections, inflammatory disorders, and certain malignancies, anemia of chronic kidney diseases, and iron-refractory iron-deficiency anemia) are also discussed.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D058990 Molecular Targeted Therapy Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease. Targeted Molecular Therapy,Molecular Targeted Therapies,Molecular Therapy, Targeted,Targeted Molecular Therapies,Targeted Therapy, Molecular,Therapy, Molecular Targeted,Therapy, Targeted Molecular
D019190 Iron Overload An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989) Overload, Iron
D023181 Antimicrobial Cationic Peptides Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane. Cationic Antimicrobial Peptide,Cationic Antimicrobial Peptides,Cationic Host Defense Peptides,Host Defense Peptide,Microbicidal Cationic Proteins,Amphipathic Cationic Antimicrobial Peptides,Host Defense Peptides,Antimicrobial Peptide, Cationic,Antimicrobial Peptides, Cationic,Cationic Peptides, Antimicrobial,Cationic Proteins, Microbicidal,Defense Peptide, Host,Defense Peptides, Host,Peptide, Cationic Antimicrobial,Peptide, Host Defense,Peptides, Antimicrobial Cationic,Peptides, Cationic Antimicrobial,Peptides, Host Defense,Proteins, Microbicidal Cationic
D027682 Cation Transport Proteins Membrane proteins whose primary function is to facilitate the transport of positively charged molecules (cations) across a biological membrane. Cation Pumps,Cation Pump,Pump, Cation,Pumps, Cation
D064451 Hepcidins Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity. Hepcidin,Liver-Expressed Antimicrobial Peptide,Pro-Hepcidin,Prohepcidin,Antimicrobial Peptide, Liver-Expressed,Liver Expressed Antimicrobial Peptide,Peptide, Liver-Expressed Antimicrobial,Pro Hepcidin

Related Publications

Tomas Ganz, and Elizabeta Nemeth
June 2017, Zhongguo shi yan xue ye xue za zhi,
Tomas Ganz, and Elizabeta Nemeth
February 2020, Biochemical and biophysical research communications,
Tomas Ganz, and Elizabeta Nemeth
August 2020, Liver international : official journal of the International Association for the Study of the Liver,
Tomas Ganz, and Elizabeta Nemeth
July 2003, Haematologica,
Tomas Ganz, and Elizabeta Nemeth
January 2011, International journal of hematology,
Tomas Ganz, and Elizabeta Nemeth
January 2010, Advances in hematology,
Copied contents to your clipboard!